Regulation of AMPK Activity by CRBN Is Independent of the Thalidomide-CRL4<sup>CRBN</sup> Protein Degradation Axis
Cereblon (CRBN), a primary target of immune-modulatory imide drugs (IMiDs), functions as a substrate receptor in the CUL4-RBX1-DDB1-CRBN (known as CRL4<sup>CRBN</sup>) E3 ubiquitin ligase complex. Binding of IMiDs to CRBN redirects the CRL4<sup>CRBN</sup> E3 ubiquitin ligase to recruit or displace i...
Spremljeno u:
| Glavni autori: | , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
MDPI AG
2021-05-01
|
| Serija: | Pharmaceuticals |
| Teme: | |
| Online pristup: | https://www.mdpi.com/1424-8247/14/6/512 |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|
